Items where Author is "Plested, E"

Feng, S ORCID: 0000-0001-7855-0991, Phillips, DJ ORCID: 0000-0003-0686-5091, White, T, Sayal, H, Aley, PK, Bibi, S, Dold, C, Fuskova, M ORCID: 0000-0002-2146-4299, Gilbert, SC ORCID: 0000-0002-6823-9750, Hirsch, I, Humphries, HE, Jepson, B, Kelly, EJ ORCID: 0000-0002-6988-8576, Plested, E, Shoemaker, K, Thomas, KM ORCID: 0000-0002-0348-654X, Vekemans, J, Villafana, TL, Lambe, T ORCID: 0000-0001-7711-897X, Pollard, AJ ORCID: 0000-0001-7361-719X et al (2021) Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection. Nature Medicine, 27 (11). pp. 2032-2040. ISSN 1078-8956

Flaxman, A, Marchevsky, NG ORCID: 0000-0003-1055-0033, Jenkin, D, Aboagye, J, Aley, PK, Angus, B, Belij-Rammerstorfer, S, Bibi, S, Bittaye, M, Cappuccini, F, Cicconi, P, Clutterbuck, EA, Davies, S, Dejnirattisai, W, Dold, C, Ewer, KJ ORCID: 0000-0001-9827-9836, Folegatti, PM ORCID: 0000-0001-5330-0240, Fowler, J, Hill, AVS, Kerridge, S et al (2021) Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002). Lancet, 398 (10304). pp. 981-990. ISSN 0140-6736

Frater, J ORCID: 0000-0001-7163-7277, Ewer, KJ ORCID: 0000-0001-9827-9836, Ogbe, A, Pace, M, Adele, S ORCID: 0000-0003-4458-1751, Adland, E, Alagaratnam, J, Aley, PK, Ali, M, Ansari, MA ORCID: 0000-0003-2790-8353, Bara, A, Bittaye, M, Broadhead, S, Brown, A, Brown, H, Cappuccini, F, Cooney, E, Dejnirattisai, W, Dold, C, Fairhead, C et al (2021) Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial. The lancet. HIV, 8 (8). e474-e485. ISSN 2405-4704

Voysey, M, Costa Clemens, SA, Madhi, SA, Weckx, LY, Folegatti, PM, Aley, PK, Angus, B, Baillie, VL, Barnabas, SL, Bhorat, QE, Bibi, S, Briner, C, Cicconi, P, Clutterbuck, EA, Collins, AM, Cutland, CL, Darton, TC, Dheda, K, Dold, C, Duncan, CJA et al (2021) Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials. The Lancet, 397 (10277). pp. 881-891. ISSN 0140-6736